MoneyWorks4Me

Nectar Lifesciences informs about board meeting

19 Jan 2026 Evaluate
Nectar Lifesciences has informed that the meeting of the Board of Directors of the Company is scheduled on 23/01/2026 to consider and approve Unaudited Financial Results for the quarter and nine months ended on December 31, 2025 and matters related thereto and other business matters, if any.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..